Abstract

2145P Thromboembolic disease associated with cyclin-dependent kinase inhibitors in patients with breast cancer

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
A dose escalation, pharmacokinetic, and pharmacodynamic study of AT7519, a cyclin-dependent kinase inhibitor in patients with refractory solid tumors
D D Von Hoff ... H Calvert
Journal of Clinical Oncology | VOL. 26
D D Von Hoff, et. al.D D Von Hoff ... H Calvert
20 May 2008
Use of tyrosine kinase inhibitors in patients with metastatic kidney cancer receiving haemodialysis: a retrospective Italian survey
Anna Lucia Manenti ... Pier Franco Conte
BJU International | VOL. 110
Anna Lucia Manenti, et. al.Anna Lucia Manenti ... Pier Franco Conte
24 Feb 2012
CDk Inhibitor for Treatment of Breast Cancer
Manzoor Ahmad Mir ... Aabida Gul
-
Manzoor Ahmad Mir, et. al.Manzoor Ahmad Mir ... Aabida Gul
01 Jan 2023
Humoral immune response to p16, a cyclin-dependent kinase inhibitor in human malignancies
Fu-Dong Shi ... Xuan-Xian Peng
Oncology Reports | VOL. 16
Fu-Dong Shi, et. al.Fu-Dong Shi ... Xuan-Xian Peng
01 Nov 2006
View more papers

More From: Annals of Oncology

Paper Title
Journal
Date
Author
Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2− advanced breast cancer: final overall survival results of MONARCH 3
M.P Goetz ... S.R.D Johnston
Annals of Oncology | VOL. -
M.P Goetz, et. al.M.P Goetz ... S.R.D Johnston
01 May 2024
Overcoming barriers in biomarker testing. Letter to the Editor regarding: ‘ESMO study on the availability and accessibility of biomolecular technologies in oncology in Europe’, by A. Bayle et al.
J García-Foncillas ... A Stenzinger
Annals of Oncology | VOL. -
J García-Foncillas, et. al.J García-Foncillas ... A Stenzinger
01 May 2024
Re: Parker CC, Petersen PM, Cook AD, et al. Timing of radiotherapy (RT) after radical prostatectomy (RP): long-term outcomes in the RADICALS-RT trial [NCT00541047]. Ann Oncol. 2024 Apr 5:S0923-7534(24)00105-4
Elio Mazzone ... Francesco Montorsi
Annals of Oncology | VOL. -
Elio Mazzone, et. al.Elio Mazzone ... Francesco Montorsi
01 May 2024
Table of Contents
-
Annals of Oncology | VOL. 35
--
01 May 2024
View more papers